• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. DENALI FEMORAL SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. DENALI FEMORAL SYSTEM Back to Search Results
Catalog Number DL900F
Device Problem Device Contamination with Chemical or Other Material (2944)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 05/20/2015
Event Type  malfunction  
Event Description
It was reported that during a vena cava retrieval procedure, the filter was retrieved with 2 legs crossed with "fibrine" on it.There was no reported pt injury.
 
Manufacturer Narrative
The lot number was not provided, therefore, the device history records could not be reviewed.The device has not been returned to the manufacturer for eval.The investigation is currently underway.
 
Manufacturer Narrative
A manufacturing review could not be performed as the lot number was not provided.The denali filter was returned.Five electronic photos were provided.Based on the returned sample condition, the investigation is confirmed for two crossed legs upon retrieval.It is unknown if the legs were crossed while implanted as procedural images were not provided.Based on the information provided, the definitive root cause is unknown.It is unknown if patient and/or procedural factors contributed to this event.Photo review: five (5) electronic photos were reviewed by (b)(6).All five photos show a denali filter with all 6 arms and legs present and intact.Clot/tissue appears to be binding two legs together.It is unknown from the photos provided if the limbs are crossed or simply bound together by the clot/tissue.Based on the photos provided, crossed limbs cannot be confirmed.The current ifu (instructions for use) states: warning/ precautions/ potential complications: delivery of the denali filter through the introducer sheath is advance only.Retraction and twisting of the pusher during delivery could result in dislodgement of the filter, crossing of filter legs or arms, and could prevent the filter from further advancement within the introducer sheath.Do not attempt to remove the denali filter if significant amounts of thrombus are trapped within the filter or if the filter snare hook is embedded within the cava wall.Care should be taken to ensure the connection between the introducer sheath hub and the filter storage tube is tight; however, the use of excessive force which can cause slippage of the threads and/or breakage of the hub should be avoided.Do not deliver the filter by pushing it beyond the end of the introducer sheath.To achieve proper placement, unsheath the stationary filter by withdrawing the introducer sheath.Do not twist the pusher at anytime during this procedure.Failure of filter expansion/incomplete expansion.The information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
 
Event Description
It was reported that during a vena cava filter retrieval, the filter was retrieved successfully; however, two crossed filter legs were identified with fibrine tissue attached.There were no reported difficulties retrieving the filter.There was no reported patient injury.
 
Manufacturer Narrative
Patient details, implant/explant dates and reason for filter placement were received from the customer facility.
 
Event Description
New information: it was reported that approximately one month post vena cava filter deployment for pe, two filter legs were discovered to be crossed with "fibrin" on it.It is unknown if the filter legs were known to be crossed prior to the retrieval of the filter.There was no reported impact or consequence to the patient.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DENALI FEMORAL SYSTEM
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 west 3rd st.
tempe AZ 85281
Manufacturer (Section G)
C.R. BARD, INC. (GFO)
289 bay road
queensbury NY 12804 2045
Manufacturer Contact
judith ludwig
1625 west 3rd st.
tempe, AZ 85281
4803032689
MDR Report Key4902737
MDR Text Key6830325
Report Number2020394-2015-00991
Device Sequence Number1
Product Code DTK
Combination Product (y/n)N
PMA/PMN Number
K130366
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative,company representative,for
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 06/03/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberDL900F
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/15/2015
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 06/03/2015
Initial Date FDA Received07/01/2015
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received01/07/2016
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age50 YR
-
-